Cargando…
DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068455/ https://www.ncbi.nlm.nih.gov/pubmed/29932513 http://dx.doi.org/10.1111/1759-7714.12785 |
| _version_ | 1783343272702246912 |
|---|---|
| author | Zhu, Zhongling Chen, Peng Yan, Zhao |
| author_facet | Zhu, Zhongling Chen, Peng Yan, Zhao |
| author_sort | Zhu, Zhongling |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6068455 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | John Wiley & Sons Australia, Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60684552018-08-03 DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer Zhu, Zhongling Chen, Peng Yan, Zhao Thorac Cancer Editorial John Wiley & Sons Australia, Ltd 2018-06-22 2018-08 /pmc/articles/PMC6068455/ /pubmed/29932513 http://dx.doi.org/10.1111/1759-7714.12785 Text en © 2018 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Editorial Zhu, Zhongling Chen, Peng Yan, Zhao DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer |
| title | DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer |
| title_full | DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer |
| title_fullStr | DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer |
| title_full_unstemmed | DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer |
| title_short | DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer |
| title_sort | dna damage response signaling as a predictive biomarker and synergistic therapeutic target for anti‐pd‐1/pd‐l1 immunotherapy in non‐small cell lung cancer |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068455/ https://www.ncbi.nlm.nih.gov/pubmed/29932513 http://dx.doi.org/10.1111/1759-7714.12785 |
| work_keys_str_mv | AT zhuzhongling dnadamageresponsesignalingasapredictivebiomarkerandsynergistictherapeutictargetforantipd1pdl1immunotherapyinnonsmallcelllungcancer AT chenpeng dnadamageresponsesignalingasapredictivebiomarkerandsynergistictherapeutictargetforantipd1pdl1immunotherapyinnonsmallcelllungcancer AT yanzhao dnadamageresponsesignalingasapredictivebiomarkerandsynergistictherapeutictargetforantipd1pdl1immunotherapyinnonsmallcelllungcancer |